Found: 155

Key Requirements and Best Practices for a Successful IPO on the Moscow Exchange

... uncertainty and enhance stability from the perspective of potential shareholders. Legal Preparation and Asset Protection Company Structuring: Before going public, it is vital for companies to arrange their corporate structure to be clear and transparent for investors. Disclosure and Protection of Intellectual Property: All legal and property rights of the company must be safeguarded, and disclosures should meet high standards. The Significance of IPO for Companies and the Market An IPO has a multifaceted impact on both the company ...

Cryptocurrency News August 10, 2025 - Bitcoin Above $116,000, Ethereum Exceeds $4,000

... seen the implementation of the comprehensive MiCA regulation in EU countries, establishing unified rules for the cryptocurrency market. The new licensing and oversight regime enhances the transparency of crypto companies’ operations and strengthens investor protection. These measures channel capital into legal frameworks and bolster Europe’s position as a center for the crypto industry. Asia: Regulatory approaches in Asia are varied. For instance, Hong Kong introduced licensing for crypto exchanges and ...

Cryptocurrency News, Tuesday, August 5, 2025 - Crypto Market Consolidates; SEC Introduces Revolutionary Crypto Initiative

... Crypto-Assets) regulation has come into force in the EU, introducing unified standards for regulating crypto assets across European countries. The new licensing and oversight regime ensures transparency in the operations of crypto companies and enhanced investor protection. This step channels capital inflows into the legal framework and strengthens Europe’s position in the global cryptocurrency market, as the rules of the game for businesses are now standardized and clear across the EU. Asia: Approaches to ...

Economic Events and Company Earnings – Thursday, July 31, 2025: U.S. Inflation, Central Bank Rates, Reports from Apple and Amazon

... year-on-year). Growth is driven by new drugs in AbbVie’s portfolio—immunology drugs (Skyrizi, Rinvoq) and aesthetic medicine products from the Botox line—that compensate for the ongoing decline in sales of the flagship drug, Humira (whose patent protection in the US has expired). Last quarter, the company lowered its annual forecast due to one-time expenses on R&D, so investors will be looking for updates on guidance now. Key aspects of the report include the rate of decline in Humira revenues in Europe and the US, the success of new medicines (market share gains), and plans to reduce debt load. If AbbVie confirms ...

Common Mistakes Made by Beginner Investors

... investing, emotions should be completely set aside. What is required are cold calculations, knowledge, perseverance, and market monitoring. Neglecting capital protection. It is not enough to merely grow one’s wealth; funds also require appropriate protection. Numerous methods to minimize risks currently exist, and it is essential to utilize the most effective strategies. Relying on simplified analysis techniques. Such methods promise to significantly ease an investor's journey and create the illusion of achieving substantial profits quickly. In reality, these methods do not account for various important factors, which always affects the final outcome. These errors should be avoided by any potential investor,...